Search Results - "Glaus Garzon, Jesus F"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis by Roblek, Marko, Protsyuk, Darya, Becker, Paul F, Stefanescu, Cristina, Gorzelanny, Christian, Glaus Garzon, Jesus F, Knopfova, Lucia, Heikenwalder, Mathias, Luckow, Bruno, Schneider, Stefan W, Borsig, Lubor

    Published in Molecular cancer research (01-03-2019)
    “…Increased levels of the chemokine CCL2 in cancer patients are associated with poor prognosis. Experimental evidence suggests that CCL2 correlates with…”
    Get full text
    Journal Article
  2. 2

    Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development by Glaus Garzon, Jesus F., Pastrello, Chiara, Jurisica, Igor, Hottiger, Michael O., Wenger, Roland H., Borsig, Lubor

    Published in Neoplasia (New York, N.Y.) (01-12-2020)
    “…•Findings provide evidence that hypoxia response deficient tumors show more functionally perfused vasculature and that TRAF6, an upstream effector of NF-κB, is…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB by Müller-Edenborn, Kamila, Léger, Karolin, Glaus Garzon, Jesus F, Oertli, Carole, Mirsaidi, Ali, Richards, Peter J, Rehrauer, Hubert, Spielmann, Patrick, Hoogewijs, David, Borsig, Lubor, Hottiger, Michael O, Wenger, Roland H

    Published in Oncotarget (21-08-2015)
    “…Two main features common to all solid tumors are tissue hypoxia and inflammation, both of which cause tumor progression, metastasis, therapy resistance and…”
    Get full text
    Journal Article
  6. 6